Insider · CIK 0001477056
John Bencich
Files at AEON (AEON Biopharma, Inc.). First filing -, latest -.
In brief
John Bencich files SEC Form 4 as CFO at AEON (AEON Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Bencich has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +754,717 | $0.00 | $0 | 754,717 | Apr 3, 2026 |
Questions about John Bencich
Answered from the filings on this page, as of the latest one.
Is John Bencich buying or selling?
John Bencich has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Bencich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Bencich has 0.
Where does John Bencich file Form 4?
John Bencich has filed Form 4 at AEON (AEON Biopharma, Inc.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.